TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 ,inter alia, to consider and approve 1. To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended December 31, 2024.Along with (Standalone &Consolidated) Limited review report thereon.2. To transact such other business as may be required.